RLMD
#2718
Relmada Therapeutics, Inc. - Common Stock
6.4 5 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.62%
Monthly Change
-3.30%
6 month change
+66.67%
Year Change
+957.38%
Previous Close
6.4 1
Open
6.4 5
Low
6.4 5
High
6.4 5
Volume
64
Financials
- Market Capitalization 676.54 M
- Employee 17
- Founded 2004
- CEO N/A
- Website www.relmada.com
- Headquarter Nevada, United States
- FIGI BBG003MKSL16
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.33
Price to sales ratio
-2 407.45
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2705 |  MNPR Monopar Therapeutics Inc. - Common Stock | 103.33 USD | -3.07% | +6.34% | +70.79% | +89.18% | 692.21 M USD | ||
| 2711 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.52 USD | +2.40% | +0.59% | +9.23% | -10.22% | 682.51 M USD | ||
| 2722 |  PTCT PTC Therapeutics, Inc. - Common Stock | 81.33 USD | -4.15% | -6.33% | +12.91% | +64.50% | 674.63 M USD | ||
| 2728 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 1.93 USD | -3.50% | -8.10% | 0.00% | +49.61% | 666.15 M USD |
Frequently asked questions about Relmada Therapeutics, Inc. - Common Stock
What is the Relmada Therapeutics, Inc. - Common Stock stock price today?
The current price of Relmada Therapeutics, Inc. - Common Stock (RLMD) is 6.45. Over the past 24 hours, the stock has changed by +0.62%. Follow the RLMD chart for real-time price dynamics.
What is the stock ticker of Relmada Therapeutics, Inc. - Common Stock?
Relmada Therapeutics, Inc. - Common Stock trades under the ticker RLMD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Relmada Therapeutics, Inc. - Common Stock stock going up?
RLMD has changed by +1.74% over the last week, -3.30% over the last month, and +957.38% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Relmada Therapeutics, Inc. - Common Stock net income for the last quarter?
Relmada Therapeutics, Inc. - Common Stock reported net income of -19.05 M for the last quarter. The previous quarter showed -19.87 M, which means net income changed by +4.11%.
How many employees does Relmada Therapeutics, Inc. - Common Stock have?
As of the latest available data, Relmada Therapeutics, Inc. - Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Relmada Therapeutics, Inc. - Common Stock stock?
You can buy Relmada Therapeutics, Inc. - Common Stock (RLMD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Relmada Therapeutics, Inc. - Common Stock stock?
Investing in Relmada Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RLMD chart and related analysis on metatrader.com as part of your research.